These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30887861)

  • 1. On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
    Duan R; Zhang X; Du J; Huang J; Tao C; Chen Y
    Health Informatics J; 2020 Jun; 26(2):753-764. PubMed ID: 30887861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing the science of pharmacovigilance.
    Honig PK
    Clin Pharmacol Ther; 2013 Jun; 93(6):474-5. PubMed ID: 23689213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA Adverse Event Reporting System: Recruiting Doctors to Make Surveillance a Little Less Passive.
    Mann JM
    Food Drug Law J; 2015; 70(3):371-94, i. PubMed ID: 26630821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of Spontaneously Reported Adverse Events].
    Nakamura M
    Yakugaku Zasshi; 2016; 136(4):549-56. PubMed ID: 27040337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
    Coloma PM; Trifirò G; Patadia V; Sturkenboom M
    Drug Saf; 2013 Mar; 36(3):183-97. PubMed ID: 23377696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database.
    Florek AG; Nardone B; Thareja S; Tran G; Giles FJ; West DP
    Br J Dermatol; 2017 Nov; 177(5):e220-e221. PubMed ID: 28646575
    [No Abstract]   [Full Text] [Related]  

  • 10. A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring.
    Lavertu A; Vora B; Giacomini KM; Altman R; Rensi S
    Clin Pharmacol Ther; 2021 May; 109(5):1197-1202. PubMed ID: 33492663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records.
    Akimoto H; Nagashima T; Minagawa K; Hayakawa T; Takahashi Y; Asai S
    Biol Pharm Bull; 2021; 44(10):1514-1523. PubMed ID: 34602560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records.
    Lee S; Choi J; Kim HS; Kim GJ; Lee KH; Park CH; Han J; Yoon D; Park MY; Park RW; Kang HR; Kim JH
    J Am Med Inform Assoc; 2017 Jul; 24(4):697-708. PubMed ID: 28087585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
    de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
    Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.
    Harpaz R; DuMouchel W; LePendu P; Bauer-Mehren A; Ryan P; Shah NH
    Clin Pharmacol Ther; 2013 Jun; 93(6):539-46. PubMed ID: 23571771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing drug safety of hepatitis C therapies using post-market data.
    Huang J; Zhang X; Tong J; Du J; Duan R; Yang L; Moore JH; Tao C; Chen Y
    BMC Med Inform Decis Mak; 2019 Aug; 19(Suppl 4):147. PubMed ID: 31391106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.
    Yu Y; Ruddy KJ; Hong N; Tsuji S; Wen A; Shah ND; Jiang G
    J Biomed Inform; 2019 Mar; 91():103119. PubMed ID: 30738946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Language Processing and Its Implications for the Future of Medication Safety: A Narrative Review of Recent Advances and Challenges.
    Wong A; Plasek JM; Montecalvo SP; Zhou L
    Pharmacotherapy; 2018 Aug; 38(8):822-841. PubMed ID: 29884988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug event monitoring at the Food and Drug Administration.
    Ahmad SR
    J Gen Intern Med; 2003 Jan; 18(1):57-60. PubMed ID: 12534765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.
    Vilar S; Friedman C; Hripcsak G
    Brief Bioinform; 2018 Sep; 19(5):863-877. PubMed ID: 28334070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.